Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Juan F. Garcı́a, Marta Pulgarín-Alfaro et al.|Nature Communications|2023Cited by 99
Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicingCristina Montero‐Conde, Mercedes Robledo, Osvaldo Graña‐Castro et al.|International Journal of Cancer|2019Cited by 40
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Mercedes Robledo, Paula Martínez et al.|Cancers|2021Cited by 24
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Mercedes Robledo, Bruna Calsina et al.|Best Practice & Research Clinical Endocrinology & Metabolism|2024Cited by 10